CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Aeon Biopharma Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Aeon Biopharma Inc
5 Park Plaza, Suite 1750
Phone: (302) 658-7581p:302 658-7581 IRVINE, CA  92614  United States Ticker: AEONAEON
Business Summary
BRIEF: For the three months ended 31 March 2026, Aeon Biopharma Inc revenues was not reported. Net loss totaled $11.8M vs. income of $9.1M. Net loss reflects Biotechnology & Medical Research segment loss increase from $462K to $5.9M. Basic Earnings per Share excluding Extraordinary Items decreased from $2.28 to -$0.29.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025YesYes---

Industries
SIC Code Description
6770 Blank checks
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board JostFischer 70 4/29/2025 4/4/2025
President, Chief Executive Officer, Director RobertBancroft 60 4/29/2025 4/29/2025
Chief Financial Officer, Principal Financial Officer John A.Bencich 49 4/1/2026 3/9/2026
7 additional Officers and Directors records available in full report.

Business Names
Business Name
AEON
AEON Biopharma Sub, Inc.Delaware
PMGM
PMGMU

General Information
Number of Employees: 8 (As of 12/31/2025)
Outstanding Shares: 26,307,211 (As of 4/21/2026)
Shareholders: 464
Stock Exchange: ASE
Federal Tax Id: 853940478
Fax Number: (302) 655-5049


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, June 30, 2026